Vivodyne

Website

Vivodyne, Inc.

18 Investors
Biotechnology
Brisbane, CA

Vivodyne, Inc. is a biotechnology company that aims to transform the understanding of human biology and the development of therapeutics through advanced technologies. By leveraging human tissue engineering, robotic automation, and predictive AI, the company enhances the accuracy of preclinical drug testing and increases the probability of clinical success.

Products & Team

Vivodyne Platform

Drug Discovery TechnologySeed

The Vivodyne Platform combines lab-grown human tissues, a robotic automation system, and predictive AI models to facilitate efficient drug discovery and testing. This integrated system allows researchers to test drugs on thousands of individual human tissue models simultaneously, enhancing the reliability of preclinical data.

Value Proposition

The platform addresses the significant uncertainty in preclinical research by providing accurate predictions of patient responses, easing the transition to clinical trials.

Pain Points

Pharmaceutical companies face high failure rates and costs due to uncertainty in patient response outcomes when transitioning from lab studies to clinical trials.

Lab-grown human organ tissues for drug testingRobotic automation for high-throughput analysisPredictive AI for identifying therapeutic targets
Industry
Other Technology
Primary business sector
Founded
2025
Year established
Location
Brisbane, CA
Primary headquarters

Funding History

Total Raised:
$77.7M
E

Equity Offering

Closed
February 2025
$77.7M
Raised
Progress
100%
Raised
$77.7M
Target
$77.7M
#000123191925000073